Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 10, 2021 / 11:00PM GMT
Release Date Price: $105.03 (-8.19%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Great. Well, we're at the top of the hour here. Do we have Guardant on Zoom? They're not coming up right now. Great. Well, looking forward to getting started here on the next panel.

Again, for those who don't know me, I'm John Sourbeer on the life sciences team. And up here with me today, I have Mike Sarcone from the med tech team also helping out, and we're excited to be hosting Guardant Health. We have Helmy Eltoukhy, CEO; AmirAli Talasaz, also Co-CEO; and then Mike Bell, who is the CFO. All right. Welcome.

Questions & Answers

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

So maybe just to get things started off. During 2Q, Guardant Health made a unique leadership announcement with the structure of the co-CEOs. Can you talk a little bit about what led to that decision and how it will impact Guardant Health's operations on both oncology and screening and how do you think it will enable Guardant Health to more

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot